Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 3/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.69 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.69 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | TK2 | O00142 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Broxuridine SCHEMBL37420 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL10316347 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL65484 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL14457631 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL27756 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL9153195 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL20769775 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL21137660 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL21423028 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL5981680 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 22388 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612662-B2 | DNA repair site detection for personal genomics, epigenomics, and gene therapy | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2026-04-28 | — | — | US | claimed |
| EP-3990021-B1 | INHIBITION OF DIPEPTIDE REPEAT PROTEINS | ALS THERAPY DEVELOPMENT INST (US) | 2026-03-18 | — | — | EP | claimed |
| US-20260071273-A1 | METHODS FOR NUCLEIC ACID SEQUENCING | NANOHYB LLC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4677107-A1 | METHOD FOR NATIVE STRAND SEQUENCING OF ENRICHED GENOMIC REGIONS | Nanohyb, LLC (US) | 2026-01-14 | — | — | EP | claimed |
| US-20260007635-A1 | INHIBITION OF DIPEPTIDE REPEAT PROTEINS | ALS THERAPY DEVELOPMENT INST (US) | 2026-01-08 | — | — | US | claimed |
| EP-4646488-A1 | ENZYMATIC DNA SYNTHESIS | The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone (US) | 2025-11-12 | — | — | EP | claimed |
| US-12447231-B2 | Human placental tissue graft products, methods, and apparatuses | CRYOLIFE, INC. (US) | 2025-10-21 | — | — | US | claimed |
| EP-4623073-A2 | METHODS FOR ASSESSING PROLIFERATION POTENCY OF GENE-EDITED T CELLS | Iovance Biotherapeutics, Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| EP-3821033-B1 | USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION | HIFIBIO SAS (FR) | 2025-09-10 | — | — | EP | claimed |
| US-20250275946-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2025-09-04 | — | — | US | claimed |
| EP-0119025-B1 | THYMIDINE KINASE-NEGATIVE TEMPERATURE RESISTANT BOVINE HERPESVIRUS-1 MUTANT AS A VACCINE AGAINST INFECTIOUS BOVINE RHINOTRACHEITIS | Baylor College of Medicine (US) | 1989-09-13 | — | — | EP | claimed |
| EP-0306985-A2 | Bacteriorhodopsin modifications and methods for their preparation | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1989-03-15 | — | — | EP | claimed |
| US-4812394-A | Flow cytomeric measurement of DNA and incorporated nucleoside analogs | UNIVERSITY OF CALIFORNIA (US) | 1989-03-14 | — | — | US | claimed |
| US-4766067-A | Gene amplification | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1988-08-23 | — | — | US | claimed |
| EP-0175286-A2 | In vitro cell culture system and method | MCW Research Foundation, Inc. (US) | 1986-03-26 | — | — | EP | claimed |
| US-4569840-A | Thymidine kinase-negative temperature resistant bovine herpesvirus-1 mutant as a vaccine against infectious bovine rhinotracheitis | BAYLOR COLLEGE OF MEDICINE (US) | 1986-02-11 | — | — | US | claimed |
| US-4529700-A | Hybridoma cells secreting a monoclonal antibody specific for 5-bromo and 5-iodoeoxyuridine and reagents for measuring cellular proliferation | UNIVERSITY OF MIAMI (US) | 1985-07-16 | — | — | US | claimed |
| EP-0119025-A2 | Thymidine kinase-negative temperature resistant bovine herpesvirus-1 mutant as a vaccine against infectious bovine rhinotracheitis | Baylor College of Medicine (US) | 1984-09-19 | — | — | EP | claimed |
| US-4465769-A | Non-transformed thymidine kinaseless cell line and its use for testing tumorigenic potential of genes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-08-14 | — | — | US | claimed |
| EP-0102228-A2 | Hybridoma secreting a monoclonal antibody specific for 5-bromo and 5-iododeoxyuridine and reagent for measuring cellular proliferation | UNIVERSITY OF MIAMI (US) | 1984-03-07 | — | — | EP | claimed |